| [1] | MATTHEW B, TIMOTHY P, CHRISTOS SK. First-line therapy for metastatic colorectal cancer: Current perspectives and future directions[J]. Asia Pac J Clin Oncol, 2019, 15(1): 3. doi: 10.1111/ajco.13042 |
| [2] | 毛跃伟, 杨松鹏, 高磊, 等. 奥沙利铂联合卡培他滨治疗晚期结肠癌的临床研究[J]. 中国临床药理学杂志, 2016, 32(14): 1286. |
| [3] | 张家洧, 杨云柯. 结直肠癌人体肿瘤移植小鼠模型的研究进展[J]. 复旦学报, 2018, 45(4): 561. doi: 10.3969/j.issn.1672-8467.2018.04.022 |
| [4] | MAGNOTTI E, MARASCO WA. The latest animal models of ovarian cancer for novel drug discovery[J]. Expert Opin Drug Discov, 2018, 13(3): 249. doi: 10.1080/17460441.2018.1426567 |
| [5] | 师长宏. 肿瘤患者来源的异种移植(PDX)模型[J]. 实验动物与比较医学, 2018, 38(3): 165. doi: 10.3969/j.issn.1674-5817.2018.03.001 |
| [6] | 唐雪莲, 付京划, 杨新颖, 等. 5-氟尿嘧啶在小鼠结肠癌模型中的药效与毒性评价研究[J]. 华南农业大学学报, 2012, 33(4): 535. |
| [7] | 朱磊, 卢静波, 陈靠山. 5-氟尿嘧啶联用拟康氏木霉胞外多糖对结肠癌移植瘤小鼠的抑瘤作用[J]. 皖南医学院学报, 2016, 35(2): 117. doi: 10.3969/j.issn.1002-0217.2016.02.004 |
| [8] | CUSACK JC, LIU R, XIA LJ, et al. NPI-0052 enhances tumoricidal response to conventional cancer therapy in a colon cancer model[J]. Clin Cancer Res, 2006, 12(22): 6758. doi: 10.1158/1078-0432.CCR-06-1151 |
| [9] | CIOMEI M, CROCI V, CIAVOLELLA A, et al. Antitumor efficacy of edotecarin as a single agent and in combination with chemotherapy agents in a xenograft model[J]. Clin Cancer Res, 2006, 12(9): 2856. doi: 10.1158/1078-0432.CCR-05-1859 |
| [10] | HARRIS SM, MISTRY P, FREATHY C, et al. Antitumour activity of XR5944 in vitro and in vivo in combination with 5-fluorouracil and irinotecan in colon cancer cell lines[J]. Br J Cancer, 2005, 92(4): 722. doi: 10.1038/sj.bjc.6602403 |